Keros Therapeutics, Inc. (KROS)
11.34
+0.35
(+3.18%)
USD |
NASDAQ |
Mar 25, 16:00
11.36
+0.02
(+0.18%)
After-Hours: 20:00
Keros Therapeutics Free Cash Flow : 105.95M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | -332.39M |
| Amicus Therapeutics, Inc. | 29.85M |
| MannKind Corp. | 13.69M |
| PTC Therapeutics, Inc. | 411.18M |
| Insmed, Inc. | -997.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.29M |
| Cash from Investing (Quarterly) | -0.134M |
| Cash from Financing (Quarterly) | -378.63M |
| Free Cash Flow Per Share (Quarterly) | -1.008 |
| Free Cash Flow to Equity (Quarterly) | -26.88M |
| Free Cash Flow to Firm (Quarterly) | -27.43M |
| Free Cash Flow Yield | 25.01% |